(Q46607007)

23 December 2017

title

Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration (English)

1 reference

23 December 2017

1 reference

1 reference

Brian P Kearney

1

1 reference

23 December 2017

Srinivasan Ramanathan

2

1 reference

23 December 2017

Andrew K Cheng

3

1 reference

23 December 2017

Ramin Ebrahimi

4

1 reference

23 December 2017

Jaymin Shah

5

1 reference

23 December 2017

publication date

1 August 2005

1 reference

23 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

23 December 2017

volume

45

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

935-940

1 reference

23 December 2017

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278949

Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278949

Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278949

Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278949

Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278949

An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278949

Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278949

Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278949

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278949

Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278949

21 January 2018

Identifiers

DOI

10.1177/0091270005278949

1 reference

23 December 2017

1 reference

23 December 2017